| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |